
Medical Foods Market Report 2026
Global Outlook – By Type (Pills, Powder, Other Types), By Application (Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Other Applications), By Sales Channel (Retail Sales, Online Sales, Institutional Sales) – Market Size, Trends, Strategies, and Forecast to 2035
Medical Foods Market Overview
• Medical Foods market size has reached to $24.37 billion in 2025 • Expected to grow to $35.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: The Aging Population's Impact On The Growth Of The Medical Foods Market • Market Trend: Adoption of Plant-Based Clinical Nutrition Solutions to Improve Disease-Related Malnutrition Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Medical Foods Market?
Medical foods refer to a food that has been prepared to be ingested or given orally under the direction of a doctor and designed for the particular dietary. It is designed to help control an existing disease or condition through food. Medical foods are exempt from the labelling requirements for nutrition content claims and health claims. The main types of medical food include pill, powder, and others. The medical food pills refer to a small pellet or a tablet often coated and consumed by swallowing whole or by chewing. Medical food pills are specially formulated to meet nutritional requirements of patients with various medical conditions such as digression, ADHD, and others. They are used in treatment of Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, and others. They are sold through online, retail, and institutional channels.
What Is The Medical Foods Market Size and Share 2026?
The medical foods market size has grown strongly in recent years. It will grow from $24.37 billion in 2025 to $26.26 billion in 2026 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing geriatric population, growing awareness of therapeutic nutrition, advancements in medical research, expansion of hospital & clinical infrastructure.What Is The Medical Foods Market Growth Forecast?
The medical foods market size is expected to see strong growth in the next few years. It will grow to $35.42 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to technological integration in nutritional monitoring, growth of online & institutional distribution channels, increasing adoption of disease-specific medical foods, rising investments in r&d for functional ingredients, expansion of home healthcare services. Major trends in the forecast period include personalized nutritional solutions, disease-specific formulations, regulatory compliance & safety standards, functional ingredients innovation, growing home healthcare adoption.Global Medical Foods Market Segmentation
1) By Type: Pills, Powder, Other Types 2) By Application: Alzheimer's Disease, Diabetic Neuropathy, Nutritional Deficiency, ADHD, Other Applications 3) By Sales Channel: Retail Sales, Online Sales, Institutional Sales Subsegments: 1) By Pills: Tablets, Capsules, Softgels 2) By Powder: Nutritional Powders, Fiber Powders 3) By Other Types: Liquid Formulations, Ready-To-Drink Products, Functional Bars And SnacksWhat Is The Driver Of The Medical Foods Market?
The increase in the geriatric population is significantly contributing to the growth of the medical foods market. At the molecular and cellular level, aging is caused by the accumulation of a range of biomolecular damage throughout time. This results in a gradual loss of functional capacity, as well as an increased risk of disease and eventually, death. These changes are not linear or continuous, and they have been only distantly related to a person's chronological age. As people get old, their dependency on certain nutritional foods increases, especially medical foods to manage their health from chronic and age-related diseases. For instance, in October 2025, according to a report published by the World Health Organization (WHO), a Switzerland-based agency responsible for international public health, by 2030, 1 in 6 people in the world will be aged 60 years or over. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). Therefore, the increase in the geriatric population is expected to propel the growth of the medical foods industry.Key Players In The Global Medical Foods Market
Major companies operating in the medical foods market are Nestlé SA, Danone SA, Fresenius Kabi AG, Mead Johnson & Company LLC, Primus Pharmaceuticals Inc., Abbott Nutrition Inc., Accera Inc., Ajinomoto Cambrooke Inc., Applied Food Sciences Inc., Cambrooke Therapeutics Inc., Danone Nutricia North America Inc., Health and Happiness (H&H) Group Limited, RFI Ingredients LLC, Solace Nutrition LLC, Targeted Medical Pharma Inc., VAYA Pharma Inc., Baxter Healthcare Corporation, Braun Melsungen AG, DuPont Nutrition & Biosciences, Enteral Nutrition Holdings Inc., Fresenius Medical Care AG & Co. KGaA, Nutricia North America Inc., Otsuka Pharmaceutical Co. Ltd., Koninklijke DSM NV, Total Parenteral Nutrition Solutions Inc.Global Medical Foods Market Trends and Insights
Major companies operating in the medical foods market are focusing on developing innovative solutions such as plant-based, nutritionally complete oral medical nutrition drinks to meet the rising demand for clinically appropriate, lactose-free, allergy-friendly, and environmentally aligned nutrition options for patients under medical supervision. A plant-based medical nutrition drink uses non-dairy protein sources such as pea and soy, providing complete macro- and micronutrient profiles comparable to traditional dairy-based formulations, while improving gastrointestinal tolerance and suitability for vegan and milk-allergic patients. For instance, in January 2023, Nutricia, a Netherlands-based medical nutrition company, launched Fortimel PlantBased Energy, its first plant-based Food for Special Medical Purposes (FSMP) formulated for the dietary management of disease-related malnutrition. The product delivers energy-dense, nutritionally complete nutrition using a pea-and-soy protein blend, supports patients with cow’s-milk protein allergy, is suitable for vegan and flexitarian diets, and is available in two flavors to enhance adherence in clinical and home-care settings.What Are Latest Mergers And Acquisitions In The Medical Foods Market?
In July 2023, Pentec Health Inc., a US-based pharmaceutical products and services company, acquired ZOIA Pharma for an undisclosed amount. The acquisition guarantees enhanced accessibility to a comprehensive range of medical foods for individuals with rare conditions. This extends to patients with phenylketonuria (PKU), who will now benefit from the latest PKU GOLIKE family of medical food products. The acquisition underscores Pentec's dedication to extending its medical food offerings into emerging and underserved regions of clinical nutrition while establishing itself as a complex care provider. ZOIA Pharma is a US-based medical food company.Regional Insights
North America was the largest region in the medical foods market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Medical Foods Market?
The medical foods market consists of sales of oral rehydration products, amino acids, and probiotics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Medical Foods Market Report 2026?
The medical foods market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the medical foods industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Medical Foods Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $26.26 billion |
| Revenue Forecast In 2035 | $35.42 billion |
| Growth Rate | CAGR of 7.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, Sales Channel |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Nestlé SA, Danone SA, Fresenius Kabi AG, Mead Johnson & Company LLC, Primus Pharmaceuticals Inc., Abbott Nutrition Inc., Accera Inc., Ajinomoto Cambrooke Inc., Applied Food Sciences Inc., Cambrooke Therapeutics Inc., Danone Nutricia North America Inc., Health and Happiness (H&H) Group Limited, RFI Ingredients LLC, Solace Nutrition LLC, Targeted Medical Pharma Inc., VAYA Pharma Inc., Baxter Healthcare Corporation, Braun Melsungen AG, DuPont Nutrition & Biosciences, Enteral Nutrition Holdings Inc., Fresenius Medical Care AG & Co. KGaA, Nutricia North America Inc., Otsuka Pharmaceutical Co. Ltd., Koninklijke DSM NV, Total Parenteral Nutrition Solutions Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
